Invention Grant
- Patent Title: Liquid pharmaceutical composition comprising an anti-IL-6 receptor antibody
-
Application No.: US16334310Application Date: 2017-09-26
-
Publication No.: US10961314B2Publication Date: 2021-03-30
- Inventor: Alessandra Del Rio , Carmela Sabina
- Applicant: FRESENIUS KABI DEUTSCHLAND GMBH
- Applicant Address: DE Bad Homburg
- Assignee: FRESENIUS KABI DEUTSCHLAND GMBH
- Current Assignee: FRESENIUS KABI DEUTSCHLAND GMBH
- Current Assignee Address: DE Bad Homburg
- Agency: Bozicevic, Field & Francis LLP
- Agent James S. Keddie
- Priority: EP16190957 20160927
- International Application: PCT/EP2017/074413 WO 20170926
- International Announcement: WO2018/060210 WO 20180405
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/30 ; C07K16/28 ; A61K9/00 ; A61K47/26 ; A61K47/18 ; A61K9/08 ; A61K47/02 ; A61K47/20 ; A61K47/22
Abstract:
The present invention relates to a novel protein formulation. In particular, the invention relates to a liquid pharmaceutical composition of an antibody directed to Interleukin-6 receptor, a method of manufacturing the composition, a kit including the composition, a package including the composition and to methods of treatment using the composition and/or package.
Public/Granted literature
- US20190218300A1 LIQUID PHARMACEUTICAL COMPOSITION Public/Granted day:2019-07-18
Information query
